Lamdong Pharmaceutical JSC
HHNX:LDP7,800.00
VND
0.00
(0.00%)
ISIN
VN000000LDP3
Return %
Stock
S&P 500
1Y
-32.17
14.20
3Y
-43.88
81.12
5Y
-43.07
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Gia Hoang Huynh Le
- Full Time Employees
- 261
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Da Lat Vietnam
- IPO Date
- Jul 20, 2010
- Website
- ladopharcorp.com
- Similar Companies
- Business
- Lamdong Pharmaceutical Joint Stock Company (Ladophar) is a Vietnam-based pharmaceutical company primarily engaged in the research, cultivation, manufacture, processing, and distribution of modern pharmaceuticals, traditional herbal remedies, standardized botanical extracts, and dietary supplements. Founded in 1982 and headquartered in Da Lat City, Lam Dong Province, Vietnam, the company is recognized as a major producer of artichoke-derived healthcare products, operating GACP-WHO-certified medicinal herb cultivation areas and WHO-GMP-compliant manufacturing facilities. The company organizes its commercial offerings into several key product segments: modern pharmaceuticals, comprising antibiotics, analgesics, antipyretics, anti-inflammatory medications, cardiovascular treatments, respiratory formulations, and gastrointestinal drugs; herbal remedies and health supplements, including liver-support tonics, detoxifying ampoules, functional capsules, concentrated artichoke resins, and effervescent formulations marketed under proprietary brands such as Ladophar and LadoActiso; functional beverages and herbal teas, featuring dried artichoke tea bags, instant herbal powders, and ready-to-drink wellness infusions; and medical equipment and supplies, encompassing diagnostic tests, sanitary disposables, and clinical consumables. In addition, the company provides contract manufacturing, toll processing, and botanical extraction services, alongside the wholesale and retail distribution of third-party healthcare products. Ladophar serves a diversified client base spanning hospitals, clinics, pharmacy chains, commercial retail outlets, and direct consumers across Vietnam, while exporting herbal extracts and finished healthcare products to international markets across Asia and Europe. In recent developments, Lamdong Pharmaceutical has executed broad corporate and operational reorganizations following major shareholder transitions, resulting in the restructuring of its Board of Directors and executive management to strengthen financial resilience and operational efficiency. The company has focused capital allocation on modernizing its extraction and processing lines, expanding its GACP-WHO standardized organic farming zones in the Central Highlands, and broadening its multi-channel distribution through strategic retail partnerships and digital commerce platforms. Additionally, Ladophar has expanded its product portfolio through the introduction of premium standardized herbal extracts and functional wellness drinks designed for both domestic health-conscious consumer segments and high-value export channels.